Neulasta

Neulasta (pegfilgrastim) is a medication used to boost the production of white blood cells in the bone marrow. It is commonly given to cancer patients undergoing chemotherapy, which can lower white blood cell counts and increase infection risk. By stimulating white blood cell growth, Neulasta helps reduce the chance of infections, allowing patients to continue their cancer treatment with less interruption. It is typically administered as an injection once per chemotherapy cycle and works by signaling the bone marrow to produce more white blood cells, supporting the body's immune defense during cancer treatment.